A Randomized Phase II Trail of Paclitaxel and Bevacizumab versus Gemcitabine, Paclitaxel, and Bevacizumab as First Line Treatment for Locally Advanced or Metastatic Breast Cancer

  • Romond, Edward (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date8/1/06 → 1/31/12